Saget heads up the event on behalf of the Scleroderma Research Foundation (SRF.)
Bob Saget, often described as one of America’s more ribald comedians” will be showing a more serious side to his nature when he steps up to the rostrum host the 31st annual Cool Comedy – Hot Cuisine to be held at the Palace Hotel in San Francisco on Wednesday, April 23rd.
Saget, an SRF Board Member, whose recently released autobiography Dirty Daddy raised a few eyebrows as he described what went on behind the scenes at his long running hit TV show knows at first hand the effects of the rare autoimmune disease, having lost his sister Gay Saget to Scleroderma twenty five years ago.
Since then Bob has been intensively involved in increasing awareness of Scleroderma as well as being a key figure in SRF’s fund raising efforts. Joining Bob on stage this year in San Francisco will be well known radio personality Don Bleu as well as comedians Dana Carvey and Jeff Garlin, while Grammy Award-winning band, Train will be providing the music.
The “Hot Cuisine” part of the evening will come under the expert care of Susan Feniger and Mary Sue Milliken, both of whom feature regularly on the Food Network’s Too Hot Tamales as well as the Top Chef Masters program on the Bravo Network.
Susan Feniger and Mary Sue Milliken will be preparing a five-course meal for the guests at the fundraiser, featuring popular dishes from their West Coast based chain of Border Grill Restaurants.
The Cool Comedy – Hot Cuisine will be presented under the financial auspices of Swiss-based pharmaceutical company Actelion, who specialize in the development of medicines to help sufferers of pulmonary arterial hypertension (PAH), one of the most deadly complications of Scleroderma.
The board of the Scleroderma Research Foundation (SRF), which is America’s primary non- profit body, involved in medical research to find a cure for Scleroderma is headed by Luke Evnin, Ph.D, managing partner at MPM Capital, a private equity firm which has invested close to $3 billion in the life sciences.
In a recent interview Dr. Evnin outlined the importance of SRF’s cooperative approach to research, which is making it possible for talented scientists from leading institutions across the nation and around the world to develop an understanding of how scleroderma begins, how it progresses and what can be done to slow, halt or reverse the disease process.
Thanks to Bob Saget, who has witnessed the devastating effects of the diseases, and Dr. Evening and Susan Feniger, both of whom have been diagnosed as being Scleroderma patients, the success of Cool Comedy – Hot Cuisine events held in San Francisco, Los Angeles and New York will continue to raise awareness of the disease as well as enable the SRF to continue to fund innovative research, which will hopefully to develop new treatment methods that will not along improve the quality of life for patients, but also substantially prolong it.